Cor Vasa 2025, 67(Suppl.3):37-40 | DOI: 10.33678/cor.2025.037

Catheter ablation of a right lateral accessory pathway using ibutilide: a case report

Michele Di Silvestroa, Marco Lo Prestia, Rosario Bonannoa, Giulia Laterraa, b, Marco Barbantia, b
a Division of Cardiology, Umberto I Hospital, ASP 4 di Enna, Enna, Italy
b Università degli Studi di Enna "Kore", Enna, Italy

Introduction: Catheter ablation of an accessory pathway can be challenging in patients with recurrent episodes of atrial fibrillation. The use of antiarrhythmics can significantly interfere with the accessory pathway, making its catheter mapping impossible.

Methods: This case report describes the use of ibutilide to prevent atrial fibrillation during endocardial catheter mapping and ablation of a right lateral accessory pathway in a young patient without significantly interfering on accessory pathway.

Conclusion: Successful catheter mapping and ablation of a right accessory pathway in a young patient with episodes of atrial fibrillation using ibutilide.

Keywords: Accessory pathway, Antiarrhythmic drug, Atrio-ventricular tachycardia, Catheter ablation, Ibutilide, Wolff-Parkinson-White syndrome,

Received: January 14, 2025; Revised: March 8, 2025; Accepted: March 9, 2025; Prepublished online: June 2, 2012; Published: September 1, 2025  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Di Silvestro M, Lo Presti M, Bonanno R, Laterra G, Barbanti M. Catheter ablation of a right lateral accessory pathway using ibutilide: a case report. Cor Vasa. 2025;67(Suppl.3):37-40. doi: 10.33678/cor.2025.037.
Download citation

References

  1. Scheinman MM, Huang SUE. The 1998 NASPE Prospective Catheter Ablation Registry. Pacing Clin Electrophysiol 2000;23:1020-1028. Go to original source... Go to PubMed...
  2. Morady F, Strickberger SA, Man KC, et al. Reasons for prolonged or failed attempt at radiofrequency catheter ablation of accessory pathways. J Am Coll Cardiol 1996;27:683-689. Go to original source... Go to PubMed...
  3. Glatter KA, Dorostkar PC, Yang Y, et al. Electrophysiological effects of ibutilide in patients with accessory pathways. Circulation 2001;104:1933-1939. Go to original source... Go to PubMed...
  4. Volgman AS, Carberry PA, Stambler B, et al. Conversion efficacy and safety of intravenous ibutilide compared with intravenous procainamide in patients with atrial flutter or fibrillation. J Am Coll Cardiol 1998;31:1414-1419. Go to original source... Go to PubMed...
  5. Voskoboinik A, Kalman E, Plunkett G, et al. A comparison of early versus delayed elective electrical cardioversion for recurrent episodes of persistent atrial fibrillation: a multi-center study. Int J Cardiol 2019;284:33-37. Go to original source... Go to PubMed...
  6. Calkins H. The 2019 ESC Guidelines for the Management of Patients with Supraventricular Tachycardia. Eur Heart J 2019;40:3812-3813. Go to original source... Go to PubMed...

This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (CC BY-NC 4.0), which permits non-comercial use, distribution, and reproduction in any medium, provided the original publication is properly cited. No use, distribution or reproduction is permitted which does not comply with these terms.





Cor et Vasa

You are accessing a site intended for medical professionals, not the lay public. The site may also contain information that is intended only for persons authorized to prescribe and dispense medicinal products for human use.

I therefore confirm that I am a healthcare professional under Act 40/1995 Coll. as amended by later regulations and that I have read the definition of a healthcare professional.